MMF GmbH
MMF GmbH is a Münster-based German Clinical Research Organization founded in 1987 that runs nationwide oncology and endometriosis quality assurance programs and registry studies on behalf of medical professional societies and pharmaceutical companies across the DACH region.
- Company typePrivate
- Founded1987
- HeadquartersMünster, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MMF GmbH does
MMF GmbH (also operating as MMF Research GmbH) is a privately held Clinical Research Organization founded in 1987 and headquartered in Münster, Germany. The company specializes exclusively in medical data collection, registry studies, pharmaceutical market research, and quality assurance in the healthcare sector, with a core focus on real-world evidence generation for oncological and hematological indications in Germany. Its service portfolio comprises disease-specific quality assurance initiatives spanning ovarian, breast, bladder, colorectal, endometrial, liver, and cervical cancers, as well as endometriosis — covering study design, electronic data capture (EDC), therapy documentation, qualitative primary market research, and clinical research instruments from setup through final publication.
The company operates on a B2B project-based professional services model with no direct consumer-facing products. It serves two primary customer segments: German medical professional societies and foundations (AGO Studiengruppe, NOGGO, AIO, AUO, Deutsche Krebsgesellschaft, SEF, GALC, DGVS, IABC) and pharmaceutical companies requiring independent real-world evidence and post-marketing surveillance. MMF functions as the operational CRO backbone for these societies, conducting nationwide representative data collection across German hospitals and office-based physicians. The company has 9 employees — a small, scientifically trained team of long-standing staff — and is managed by two Geschäftsführer (Managing Directors), Markus Kerkmann and Josef Nietsch. Revenue is project-based and contract-negotiated, with no public pricing disclosed. The company is independently owned with no parent, no subsidiaries, no funding rounds, and no patent or award disclosed in the available data.
MMF GmbH firmographics
Firmographics- Name
- MMF GmbH
- Legal name
- MMF GmbH
- Website
- https://mmf-research.de
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MMF GmbH is a Münster-based German Clinical Research Organization founded in 1987 that runs nationwide oncology and endometriosis quality assurance programs and registry studies on behalf of medical professional societies and pharmaceutical companies across the DACH region.
- Ownership category
- akta.pro rank
MMF GmbH industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where MMF GmbH is headquartered
LocationHeadquarters
- HQ city
- Münster
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
MMF GmbH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- CRO Services for Medical Societies: Project-based contract research services conducting registry studies and quality assurance programs on behalf of medical professional societies and foundations such as AGO Studiengruppe, AIO, AUO, and Deutsche Krebsgesellschaft.
- CRO Services for Pharmaceutical Companies: Clinical research services for pharmaceutical companies supporting real-world evidence generation and post-marketing surveillance studies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MMF GmbH product offering
Product offeringCore offering
MMF GmbH is a Clinical Research Organization that operates as a CRO on behalf of medical professional societies, foundations, and pharmaceutical companies. It conducts nationwide registry studies and quality assurance programs documenting treatment patterns and outcomes across multiple oncology indications (ovarian, breast, bladder, colorectal, endometrial, cervical, and liver cancer), as well as endometriosis, accompanying each study from setup through final publication. Complementary offerings include patient therapy documentation, therapy monitors, qualitative primary market research, and clinical research instruments.
Product overview
MMF Research GmbH operates as a Clinical Research Organization offering a comprehensive portfolio of quality assurance initiatives for oncology and hematology treatment monitoring. The core offering consists of disease-specific registry studies including QS-OVAR (ovarian cancer), QS-Mamma (breast cancer), QS-Harnblase (bladder cancer), QS-mCRC (colorectal cancer), QS-SEC (endometrial cancer), QLC (liver cancer), QS-ENDO (endometriosis), ATTICI (urothelial cancer biomarkers), and QS-CXmet (cervical cancer). These are complemented by patient therapy documentation services, therapy monitors, qualitative primary market research, and clinical research instruments. The company functions as a CRO conducting studies from setup through final publication on behalf of medical societies, foundations, and pharmaceutical companies.
Differentiator
Problem solved
Functional benefit
Products and services
- QS-OVAR (Qualitätssicherung Ovarialkarzinom) Quality assurance initiative for ovarian cancer treatment monitoring, tracking therapy standards and patient outcomes across German hospitals.
- QS-Mamma (Therapie des Mammakarzinoms) Quality assurance initiative for breast cancer treatment documentation and therapy monitoring in Germany.
- QS-Harnblase (Harnblasenkarzinom) Quality assurance initiative for bladder cancer treatment quality monitoring and documentation.
- QS-mCRC (Metastasiertes Kolorektales Karzinom) Quality assurance initiative for metastatic colorectal cancer treatment documentation and outcomes tracking.
- QS-SEC (Qualitätssicherung Endometriumkarzinom) Quality assurance initiative for endometrial cancer clinical management and outcome evaluation.
- QLC (Leberkrebs und biliäre Karzinome) Quality assurance initiative for liver cancer and biliary tract carcinoma treatment documentation.
- QS-ENDO (Qualitätssicherung Endometriose) Quality assurance initiative for endometriosis treatment and care quality in the DACH region.
- ATTICI Biomarker Study Real-world data study on alternative therapeutic targets in patients treated with immune checkpoint inhibitors for advanced urothelial cancer.
- QS-CXmet (Metastasiertes Zervixkarzinom) Quality assurance initiative for metastatic cervical cancer patient characteristics and therapeutic treatment strategies evaluation.
- Therapiedokumentationen / Therapiemonitore Patient documentation services for current cancer therapies and treatment monitoring, provided as a CRO service.
- Qualitative Primärmarktforschung Qualitative primary market research services in the healthcare sector, delivered on behalf of clients.
- Instrumente (Clinical Research Instruments) Clinical research instruments for data collection and quality assessment in medical studies.
Quantifiable outcome
- Ongoing quality assurance programs document treatment and outcomes for thousands of cancer patients annually across Germany
- +1 more outcomes
Companies that use MMF GmbH
Customer profileSegments2 records
Ideal customer profiles2 records
MMF GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MMF GmbH partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- AGO Studiengruppe (Arbeitsgemeinschaft Gynäkologische Onkologie)coreLong-standing partnership conducting quality assurance programs for ovarian cancer (QS-OVAR), breast cancer (QS-Mamma), and cervical cancer. AGO is a major German gynecological oncology research network.
- NOGGO e.V.corePartner in ovarian cancer quality assurance initiatives (QS-OVAR). NOGGO is a German research organization for gynecological oncology.
- AIO (Arbeitsgemeinschaft Internistische Onkologie)coreCollaboration on colorectal cancer (QS-mCRC), bladder cancer, and supportive care quality assurance programs. AIO is the German working group for medical oncology within the German Cancer Society.
- AUO (Arbeitsgemeinschaft Urologische Onkologie)corePartnership on bladder cancer quality assurance initiatives (QS-Harnblase). AUO is the German urological oncology working group.
- Deutsche Krebsgesellschaft (DKG / German Cancer Society)coreQuality assurance initiatives conducted on behalf of the German Cancer Society and its working groups including AIO and AGSMO.
- Stiftung Endometrioseforschung (SEF)corePartnership on endometriosis quality assurance programs (QS-ENDO Pilot, QS-ENDO Real) assessing care quality in certified endometriosis centers in the DACH region.
- German Alliance on Liver Cancer (GALC)corePartnership on quality assurance initiative for liver cancer and biliary tract carcinoma therapy (QLC) in Germany.
- IABC (Interdisziplinäre Arbeitsgruppe BlasenCarcinom)minorInterdisciplinary working group supporting bladder cancer quality assurance initiatives in collaboration with AUO and AIO.
- DGVS (Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten)minorPartner in metastatic colorectal cancer quality assurance initiative (QS-mCRC).
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
MMF GmbH competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Major global CRO with real-world and late-phase service lines that compete for the same pharma registry and quality assurance budgets MMF accesses through society partnerships.
- IQVIA: Global full-service CRO and real-world evidence provider that competes with MMF for pharma-sponsored registry and post-marketing surveillance work, but at vastly greater scale and as part of a broader commercial/clinical services portfolio.
- ICON plc: Large global CRO with established real-world evidence and late-phase research capabilities that overlap with MMF's service mix, addressing the same pharma client segments worldwide.
Direct peers
- ClinLife (formerly ClinCompetence): German CRO providing clinical study management and registry/observational study services to medical societies and pharmaceutical companies, aligned with MMF's indication registry focus.
- iOMEDICO GmbH: German CRO headquartered in Freiburg specializing in hematology and oncology real-world evidence, registry studies, and quality assurance — closely paralleling MMF's operating model, indication footprint, and society partnerships.
- Winicker Norimed GmbH: German CRO offering clinical research, registry, and health economics services to medical societies and pharma sponsors, with overlapping German-market customers and a similar project-based service model.
- GKM Gesellschaft für Therapieforschung mbH: Munich-based clinical research organization conducting therapy studies, registry work, and pharma-sponsored research in Germany — comparable boutique CRO serving similar society and sponsor segments.
- Alcedis GmbH: Germany-based clinical research and registry specialist focused on real-world data, clinical evaluation, and post-market studies in oncology and chronic disease — directly comparable service portfolio and customer base to MMF.
Others
- DocMorris / Aposan real-world evidence group: German healthcare-adjacent providers of real-world data and registry-adjacent services; thematically comparable as DACH-based RWE ecosystem participants rather than direct head-to-head CRO competitors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
MMF GmbH social profiles
Digital presenceMMF GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
MMF GmbH leadership team
Management profileNumber of profiles
Profiles2 records
MMF GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MMF GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MMF GmbH
What does MMF GmbH do?
MMF GmbH is a Clinical Research Organization that operates as a CRO on behalf of medical professional societies, foundations, and pharmaceutical companies. It conducts nationwide registry studies and quality assurance programs documenting treatment patterns and outcomes across multiple oncology indications (ovarian, breast, bladder, colorectal, endometrial, cervical, and liver cancer), as well as endometriosis, accompanying each study from setup through final publication. Complementary offerings include patient therapy documentation, therapy monitors, qualitative primary market research, and clinical research instruments.
Is MMF GmbH a public or private company?
MMF GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MMF GmbH founded?
MMF GmbH was founded in 1987. It employs 1 to 10 people.
Where is MMF GmbH based?
MMF GmbH is headquartered in Münster, Germany, in the Europe region.
How does MMF GmbH make money?
Two revenue lines are on record. CRO Services for Medical Societies are the primary driver. The others are CRO Services for Pharmaceutical Companies.
Who are MMF GmbH's main competitors?
Broad incumbents on record are Parexel International, IQVIA and ICON plc. Direct peers are ClinLife (formerly ClinCompetence), iOMEDICO GmbH, Winicker Norimed GmbH, GKM Gesellschaft für Therapieforschung mbH and Alcedis GmbH. DocMorris / Aposan real-world evidence group is listed as an others.
Does MMF GmbH have an API?
No public API is recorded for MMF GmbH.
What industry is MMF GmbH in?
MMF GmbH's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 54171 and its SIC code is 8000.